These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1292355)

  • 21. [The effect of calcium antagonists, partusisten, oxytocin and prostenon on uterine contractile activity in pregnant rats].
    Korkhov VV; Abdullaev DN
    Eksp Klin Farmakol; 1995; 58(6):40-1. PubMed ID: 8704611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of ginipral (hexoprenaline) in threatened premature labor, acute fetal hypoxia and uncoordinated labor activity].
    Strizhova NV; Hamdan S; Tuminova SN; Komarova EE
    Akush Ginekol (Mosk); 1993; (2):30-2. PubMed ID: 8048666
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of partusisten in threatened abortion].
    Gurova AI; Gridchik LP; Afanas'eva GV; Krapivkina IG
    Akush Ginekol (Mosk); 1978 Jul; (7):38-40. PubMed ID: 356639
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of uterine contraction curve registered by external tocography in imminent premature delivery with tocolytic treatment being given special consideration].
    Torbé A
    Ann Acad Med Stetin; 1993; 39():167-83. PubMed ID: 8154617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Magnesium sulfate treatment of threatened late abortions and premature labor].
    Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D
    Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the use of fenoterolhydrobromide in the treatment of imminent abortion (author's transl)].
    Ruppin E; Eberhard F; Chelius HH
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):461-7. PubMed ID: 669234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of tocolytic efficacy of selective beta2 adrenoceptor agonists on buffalo uterus.
    Garg SK; Garg KM; Sabir M
    Indian J Exp Biol; 2004 Sep; 42(9):913-8. PubMed ID: 15462186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical use of a beta-mimetic drug in the control of uterine dynamics].
    Casati G; Scaglione V; Vandelli I
    Ann Ostet Ginecol Med Perinat; 1973; 94(9-10):587-94. PubMed ID: 4806144
    [No Abstract]   [Full Text] [Related]  

  • 30. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathogenetic treatment with tocolytic drugs of pregnant women with threatened premature labor].
    Murashko LE; Karibaeva BZh
    Akush Ginekol (Mosk); 1987 Oct; (10):30-4. PubMed ID: 2893558
    [No Abstract]   [Full Text] [Related]  

  • 32. [The tocolytic activity of melatonin].
    Drogovoz SM; Ryzhenko IM
    Eksp Klin Farmakol; 1993; 56(6):23-5. PubMed ID: 8111289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cervical length to the efficacy of nifedipine and bed rest for inhibiting threatened preterm labor.
    Chawanpaiboon S; Sutantawibul A
    J Med Assoc Thai; 2012 May; 95(5):636-43. PubMed ID: 22994021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of tocolytic drugs on oxytocin-induced uterine contractility in vitro].
    Muñoz H; Marusic E
    Rev Chil Obstet Ginecol; 1992; 57(3):159-70. PubMed ID: 1342732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tocolytic effects of nitric oxide. Introduction to an experimental approach].
    Pasquier JC
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):148-9. PubMed ID: 9471446
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment of threatened abortion with Partusisten (preparation Th 1165 A)].
    Dzioba A; Sward J; Gajewski A; Smulikowski A
    Wiad Lek; 1975 Jul; 28(14):1193-6. PubMed ID: 1162990
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fenoterol for section].
    Fingerhut D; Burgard G
    Anaesthesist; 1997 Feb; 46(2):174. PubMed ID: 9133180
    [No Abstract]   [Full Text] [Related]  

  • 38. [Is surgical-tocolytic prevention and therapy of cervical insufficiency justified without prenatal diagnostic care?].
    Bergner R; Fröhlich HH
    Zentralbl Gynakol; 1977; 99(26):1624-8. PubMed ID: 607700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pros and cons of magnesium sulfate as a tocolytic].
    Bozhinova S; Markova S; Tsvetkov Ts; Penkov V; Ivanova I
    Akush Ginekol (Sofiia); 2002; 41(6):17-22. PubMed ID: 12577499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action of orciprenaline administrated orally in threatened abortion].
    Uranga Imaz FA; Goñi JA; Selva A
    Obstet Ginecol Lat Am; 1973; 31(9-10):352-8. PubMed ID: 4806747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.